Literature DB >> 6785796

The effect of long-term concurrent administration of chlorpromazine and lithium on the striatal and frontal cortical dopamine metabolism in rats.

L Eroğlu, A Hizal, H Koyuncuoğlu.   

Abstract

The effects of lithium and chlorpromazine chronically administered alone and together on the dopamine metabolism in the rat striatum and frontal cortex were investigated by measurement of the levels of dopamine (DA) and its main metabolite, homovanillic acid (HVA). Long-term chlorpromazine administration caused a significant increase in the striatal DA level and a decrease in that of HVA and HVA/DA ratio without any changes in those of the frontal cortex. The prolonged administration of lithium elevated the striatal levels of both HVA and DA, but no change in the frontal cortex was observed. The concurrent administration of chlorpromazine and lithium caused a significant increase in the frontal cortical DA level and a decrease in that of HVA and HVA/DA ratio. The striatal DA and HVA levels increased under the effect of the combined treatment, while the HVA/DA ratio remained unchanged.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6785796     DOI: 10.1007/BF00431108

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  19 in total

1.  The acute and chronic effects of D-amphetamine, chlorpromazine, amitriptyline and lithium chloride on adenosine 5-triphosphatases in different regions of the rat brain.

Authors:  J McNulty; D J O'Donovan; B E Leonard
Journal:  Biochem Pharmacol       Date:  1978-04-01       Impact factor: 5.858

2.  Acidic dopamine metabolites in cortical areas of the rat brain: localization and effects of drug.

Authors:  B H Westerink; J Korf
Journal:  Brain Res       Date:  1976-08-27       Impact factor: 3.252

3.  Effects of morphine on the rat striatal dopamine metabolism.

Authors:  C M Lee; P C Wong
Journal:  Biochem Pharmacol       Date:  1979       Impact factor: 5.858

4.  On the interaction of 5-hydroxytryptophan and 5-hydroxytryptamine with dopamine metabolism in the rat striatum.

Authors:  N Awazi; H C Guldberg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-05       Impact factor: 3.000

5.  Effect of lithium on brain dopamine.

Authors:  E Friedman; S Gershon
Journal:  Nature       Date:  1973-06-29       Impact factor: 49.962

6.  A rapid and sensitive procedure for the combined assay of noradrenaline, dopamine AND SEROTONIN IN A SINGLE BRAIN SAMPLE.

Authors:  G B Ansell; M F Beeson
Journal:  Anal Biochem       Date:  1968-05       Impact factor: 3.365

7.  The effect of lithium upon brain neuroamines.

Authors:  E L Bliss; J Ailion
Journal:  Brain Res       Date:  1970-12-01       Impact factor: 3.252

8.  Rapid development of hypersensitivity of striatal dopamine receptors induced by alpha-methylparatyrosine and its prevention by protein synthesis inhibitors.

Authors:  J Costentin; H Marçais; P Protais; M Baudry; S De La Baume; M P Martres; J C Schwartz
Journal:  Life Sci       Date:  1977-08-01       Impact factor: 5.037

9.  Combined haloperidol and lithium carbonate in treating manic patients.

Authors:  N R Krishna; M A Taylor; R Abrams
Journal:  Compr Psychiatry       Date:  1978 Mar-Apr       Impact factor: 3.735

10.  Clozapine: reduction of the initial dopamine turnover increase by repeated treatment.

Authors:  P C Waldmeier; L Maître
Journal:  Eur J Pharmacol       Date:  1976-07       Impact factor: 4.432

View more
  1 in total

1.  Lithium does not interact with haloperidol in the dopaminergic pathways of the rat brain.

Authors:  A Reches; V Jackson-Lewis; S Fahn
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.